Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination
暂无分享,去创建一个
C. Agrati | G. Ippolito | E. Cimini | C. Castilletti | R. Casetti | M. Capobianchi | V. Puro | D. Goletti | F. Colavita | D. Lapa | G. Matusali | S. Meschi | Saeid Najafi Fard | A. Aiello | A. Agresta | Eleonora Tartaglia | P. Gallì | S. Leone | On Behalf Of The Inmi Covid-Vaccine Study Group | Chiara Farrone
[1] D. Murdoch,et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data , 2021, The Lancet. Digital health.
[2] M. Davenport,et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection , 2021, Nature Medicine.
[3] G. Parmigiani,et al. Influenza Vaccination and COVID-19 Mortality in the USA: An Ecological Study , 2021, Vaccines.
[4] G. Ippolito,et al. SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus , 2021, Viruses.
[5] J. Nachega,et al. Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection — Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base , 2021, International Journal of Infectious Diseases.
[6] A. Gasbarrini,et al. Effect of influenza vaccine on COVID-19 mortality: a retrospective study , 2021, Internal and Emergency Medicine.
[7] J. Lewnard,et al. Prevention of Coronavirus Disease 2019 Among Older Adults Receiving Pneumococcal Conjugate Vaccine Suggests Interactions Between Streptococcus pneumoniae and Severe Acute Respiratory Syndrome Coronavirus 2 in the Respiratory Tract , 2021, The Journal of infectious diseases.
[8] J. Teijaro,et al. COVID-19 vaccines: modes of immune activation and future challenges , 2021, Nature Reviews Immunology.
[9] H. Schaal,et al. Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination , 2021, medRxiv.
[10] N. Islam,et al. Association between influenza vaccination and hospitalisation or all-cause mortality in people with COVID-19: a retrospective cohort study , 2021, BMJ Open Respiratory Research.
[11] C. Creech,et al. SARS-CoV-2 Vaccines. , 2021, JAMA.
[12] K. Eagle,et al. Impact of the influenza vaccine on COVID-19 infection rates and severity , 2021, American Journal of Infection Control.
[13] L. Howard. Is There an Association Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Streptococcus pneumoniae? , 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.
[14] R. Grilli,et al. Association between Exposure to Influenza Vaccination and COVID-19 Diagnosis and Outcomes , 2020, Vaccines.
[15] L. Brammer,et al. Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020 , 2020, American Journal of Transplantation.
[16] M. Netea,et al. Trained Innate Immunity, Epigenetics, and Covid-19. , 2020, The New England journal of medicine.
[17] P. McCartney. Sex-Based Vaccine Response in the Context of COVID-19 , 2020, Journal of Obstetric, Gynecologic & Neonatal Nursing.
[18] A. Venkatakrishnan,et al. Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations , 2020, Scientific Reports.
[19] N. Messina,et al. The impact of vaccines on heterologous adaptive immunity. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[20] M. Netea,et al. BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study. , 2015, The Journal of infectious diseases.